Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Outcome domains for studies of acute and chronic gout.

Literature DB >> 19820223

Outcome domains for studies of acute and chronic gout.

H Ralph Schumacher¹, William Taylor, Lawrence Edwards, Rebecca Grainger, Naomi Schlesinger, Nicola Dalbeth, Francisca Sivera, Jasvinder Singh, Robert Evans, Royce W Waltrip, Cesar Diaz-Torne, Patricia MacDonald, Fiona McQueen, Fernando Perez-Ruiz.

Abstract

Discussion and voting at OMERACT 9 confirmed 5 essential domains for outcomes of acute gout: pain, joint swelling, joint tenderness, patient global assessment and activity limitations. For studies in chronic gout 7 essential domains are: serum urate, acute gout attacks, tophus burden, health-related quality of life, activity limitations, pain, and patient global assessment. Implications of patient perspectives, discretionary domains for specific studies, measurement instruments and a possible responder index are under study.

Entities: Chemical Disease Species

Mesh：

Substances：
Uric Acid

Year: 2009 PMID： 19820223 DOI： 10.3899/jrheum.090370

Source DB: PubMed Journal: J Rheumatol ISSN： 0315-162X Impact factor: 4.666

Keyword Cloud
Cited

46 in total

1. Oral colchicine (colcrys®) in the treatment and prophylaxis of gout†: profile report.

Authors: Lily P H Yang
Journal: Drugs Aging Date: 2010-10-01 Impact factor: 3.923

Review 2. Imaging as an Outcome Measure in Gout Studies: Report from the OMERACT Gout Working Group.

Authors: Rebecca Grainger; Nicola Dalbeth; Helen Keen; Laura Durcan; N Lawrence Edwards; Fernando Perez-Ruiz; Cesar Diaz-Torne; Jasvinder A Singh; Dinesh Khanna; Lee S Simon; William J Taylor
Journal: J Rheumatol Date: 2015-02-01 Impact factor: 4.666

3. Patient-reported outcomes in chronic gout: a report from OMERACT 10.

Authors: Jasvinder A Singh; Will J Taylor; Lee S Simon; Puja P Khanna; Lisa K Stamp; Fiona M McQueen; Tuhina Neogi; Angelo L Gaffo; Michael A Becker; Patricia A MacDonald; Omar Dabbous; Vibeke Strand; Nicola D Dalbeth; Daniel Aletaha; N Lawrence Edwards; H Ralph Schumacher
Journal: J Rheumatol Date: 2011-07 Impact factor: 4.666

4. Tophus measurement as an outcome measure for clinical trials of chronic gout: progress and research priorities.

Authors: Nicola Dalbeth; Fiona M McQueen; Jasvinder A Singh; Patricia A MacDonald; N Lawrence Edwards; H Ralph Schumacher; Lee S Simon; Lisa K Stamp; Tuhina Neogi; Angelo L Gaffo; Puja P Khanna; Michael A Becker; William J Taylor
Journal: J Rheumatol Date: 2011-07 Impact factor: 4.666

Review 5. Outcome measures in acute gout: a systematic literature review.

Authors: Nicola Dalbeth; Cathy S Zhong; Rebecca Grainger; Dinesh Khanna; Puja P Khanna; Jasvinder A Singh; Fiona M McQueen; William J Taylor
Journal: J Rheumatol Date: 2013-12-15 Impact factor: 4.666

6. OMERACT endorsement of measures of outcome for studies of acute gout.

Authors: Jasvinder A Singh; William J Taylor; Nicola Dalbeth; Lee S Simon; John Sundy; Rebecca Grainger; Rieke Alten; Lyn March; Vibeke Strand; George Wells; Dinesh Khanna; Fiona McQueen; Naomi Schlesinger; Annelies Boonen; Maarten Boers; Kenneth G Saag; H Ralph Schumacher; N Lawrence Edwards
Journal: J Rheumatol Date: 2013-12-15 Impact factor: 4.666

Outcome domains for studies of acute and chronic gout.

1. Oral colchicine (colcrys®) in the treatment and prophylaxis of gout†: profile report.

Review 2. Imaging as an Outcome Measure in Gout Studies: Report from the OMERACT Gout Working Group.

3. Patient-reported outcomes in chronic gout: a report from OMERACT 10.

4. Tophus measurement as an outcome measure for clinical trials of chronic gout: progress and research priorities.

Review 5. Outcome measures in acute gout: a systematic literature review.

6. OMERACT endorsement of measures of outcome for studies of acute gout.

7. A qualitative and quantitative analysis of the characteristics of gout patient education resources.

8. Improvement in OMERACT domains and renal function with regular treatment for gout: a 12-month follow-up cohort study.

9. Methods of assessment of tophus and bone erosions in gout using dual-energy CT: reproducibility analysis.

Review 10. Febuxostat for treating chronic gout.